edoc

Items where Author is "Ilunga, M."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2021 | 2012 | 2009
Number of items: 3.

2021

Kümmerle, A. and Schmid, C. and Bernhard, S. and Kande, V. and Mutombo, W. and Ilunga, M. and Lumpungu, I. and Mutanda, S. and Nganzobo, P. and Tete, D. N. and Kisala, M. and Burri, C. and Blesson, S. and Valverde Mordt, O.. (2021) Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: report from a field study. PLoS Negl Trop Dis, 15 (11). e0009903.

2012

Schmid, C. and Kümmerle, A. and Blum, J. and Ghabri, S. and Kande, V. and Mutombo, W. and Ilunga, M. and Lumpungu, I. and Mutanda, S. and Nganzobo, P. and Tete, D. and Mubwa, N. and Kisala, M. and Blésson, S. and Mordt, O. V.. (2012) In-hospital safety in field conditions of nifurtimox eflornithine combination therapy (NECT) for T.b. gambiense sleeping sickness. PLoS Neglected Tropical Diseases, 6 (11). e1920.

2009

Priotto, G. and Kasparian, S. and Mutombo, W. and Ngouama, D. and Ghorashian, S. and Arnold, U. and Ghabri, S. and Baudin, E. and Buard, V. and Kazadi-Kyanza S., and Ilunga, M. and Mutangala, W. and Pohlig, G. and Schmid, C. and Karunakara, U. and Torreele, E. and Kande, V.. (2009) Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial. Lancet : a journal of British and foreign medicine, surgery, obstetrics, physiology, chemistry, pharmacology, public health and news, Vol. 374, no. 9683. pp. 56-64.

This list was generated on Tue Mar 19 09:22:34 2024 CET.